Rehabilitation Research

eMagin 3DVisor Implemented by Medicaa Into FDA-Approved Rehabilitation Unit

Published in Medical Letter on the CDC and FDA, April 8th, 2007

Medicaa (www.medicaa.com), has developed a new therapeutic application for eMagin's (OTC:EMAN) Z800 3DVisor. The medical hardware developer has integrated the popular gaming device into its Balance Rehabilitation Unit (BRU), for treating patients with balance disorders, vertigo or instability.

Approved earlier this month by the U.S. Food & Drug Administration, the BRU(TM) uses the Z800 3DVisor to selectively stimulate the neural processes involved in the vestibular compensation mechanisms. The BRU enables the physician to assess the extent of the problem and treat it. Assessment involves analyzing a patients a series of postures as he or she receives a specific sensory...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-04-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry